How does the operation of PHARMAC's 'Community Exceptional ...

Free Node Description of Information Contained in the Node
Method of Collecting Data Comments made by interviewees during interviews or other
information about how the data was collected.
MoH and Medsafe Material relating to and comments made about the Ministry of Health
or Medsafe
New Treatment Material relating to new treatments particularly the costs of treatment
and decision making about approving new treatments onto the
Pharmaceutical Schedule
NICE (UK) References to the National Institute of Clinical Excellence which
similar body in the UK to PHARMAC.
Not Sure Where to Code Where references didn’t seem to fit or relate to a node.
Sometimes material was removed from this node and placed in a new
node.
OIA Requests Material relating to the Official Information Act requests or material
about information which was withheld under the Act.
PHARMAC Staff ‘Feelings’ Material which expressed, indicated or related to how the PHARMAC
felt about what it was like for them to do their work
PHARMAC’s Policies and
Procedures
PHARMAC’s Relationship with
Drug Companies
Material relating to PHARMACs policies and procedures or the way
they went about making decisions which were outside their policies or
procedures.
Information referred to in either the documents or the interviews which
described aspects of the relationship with pharmaceutical
manufacturing companies.
Political Risk Material indicating the identification or management of political risk
either by PHARMAC or the Government
PTAC References to the selection, activities, criteria and decisions made by
PTAC
Rare treatments Material relating to rare treatments as opposed to expensive
treatments
Rawls References to philosopher Rawls, material about justice as fairness,
providing for those in greatest need, openness and accountability as a
function of fairness.
Reference Pricing Material referring to reference pricing mechanism used by
PHARMAC.
Reviews of PHARMAC Reviews which have taken place and examine aspects of
PHARMAC’s performance, policies and procedures.
Researched Medicines Institute
(RMI)
Material related to the RMI either by the RMI or about the RMI
Rule of Rescue References to the Rule of Rescue
Source of Material Where there are embedded references in the interviews or documents
to the sources of material the interviewee or document are referring to
in the data.
Taxpayers Interests Comments or written passages which explain issues from the point of
view of the taxpayer, or the general health budget
The Number “10” Material relating to the use of “10” cases nationally of any condition as
a description of rarity
102